Abattis Bioceuticals Corp (CNSX:ATT) shares rose 6.7% during trading on Thursday . The stock traded as high as C$0.08 and last traded at C$0.08. Approximately 101,793 shares were traded during trading, a decline of 93% from the average daily volume of 1,420,000 shares. The stock had previously closed at C$0.08.

ILLEGAL ACTIVITY WARNING: This report was published by Watch List News and is owned by of Watch List News. If you are reading this report on another publication, it was illegally copied and republished in violation of United States and international trademark & copyright legislation. The legal version of this report can be viewed at https://www.watchlistnews.com/abattis-bioceuticals-att-stock-price-up-6-7/2789405.html.

About Abattis Bioceuticals (CNSX:ATT)

Abattis Bioceuticals Corp. is a specialty biotechnology company. The Company aggregates, incubates, integrates and invests in the natural health product and botanical drug development industry. It operates through the segment of producing, licensing and marketing ingredients and formulas for use in the biopharma, nutraceutical, cosmetic and animal nutrition markets.

Featured Article: Do investors pay a separate front-end load every time they buy additional shares?

Receive News & Ratings for Abattis Bioceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abattis Bioceuticals and related companies with MarketBeat.com's FREE daily email newsletter.